Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites

• Gregory M. Dillon ,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft

  * E-mail: greg.dillon@biogen.com

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0002-3673-284X

  ⨯
• Jaclyn L. Henderson,

  Roles Conceptualization, Investigation, Methodology, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0002-7097-1350

  ⨯
• Channa Bao,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  ⨯
• John A. Joyce,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0003-0138-714X

  ⨯
• Michael Calhoun,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0003-4323-4053

  ⨯
• Brenda Amaral,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  ⨯
• Kristopher W. King,

  Roles Investigation

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0003-3104-1609

  ⨯
• Bekim Bajrami,

  Roles Investigation, Project administration, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  http://orcid.org/0000-0002-4129-9390

  ⨯
• Dania Rabah

  Roles Conceptualization, Writing – review & editing

  Affiliation Biogen, Cambridge, MA, United States of America

  ⨯